materiaux

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers. Led by Co-director Ralph Weichselbaum, investigator Wenbin Lin and postdoctoral researcher Kaiting Yang at the Ludwig Center at Chicago, the study describes the synthesis, mechanism of action and preclinical assessment of the nanoparticle, which is loaded with a drug that activates a protein central to the efficient induction of anti-cancer immunity.

The bar was undoubtedly set high: In the research project Functional Oxides Printed on Polymers and Paper – FOXIP for short – the goal was to succeed in printing thin-film transistors on paper substrates or PET films. Electronic circuits with such elements play an important role in the growing Internet of Things (IoT), for example as sensors on documents, bottles, packaging … – a global market worth billions.